Stage II 29 (37.5) III 45 (55) IV 6 (7.5) | 3 (10.3) 26 (89.7) 14 (31.1) 31 (68.9) (p > 0.05) 3 (50) 3 (50) |
Type of Tumor IDC 67 (83.75) ILC 13 (16.25) | 16 (23.9) 51 (76.1) (p > 0.001) 4 (30.8) 9 (69.2) |
Lymph Node Positive 67 (85) Negative 13 (15) | 17 (25.4) 50 (74.6) (p < 0.001) 3 (23.1) 10 (76.9) |
Estrogen Receptor Positive54 (67.5) Negative 26 (32.5) | 12 (22.3) 42 (77.7) (p < 0.05) 8 (30.8) 18 (69.2) |
Progesterone Receptor Positive 42 (52.5) Negative 38 (47.5) | 8 (19) 34 (81) (p < 0.05) 12 (31.6) 26 (68.4) |
HER2/NEU Positive 30 (37.5) Negative 50 (62.5) | 6 (20) 24 (80) (p < 0.05) 14 (28) 36 (72) |